BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8167704)

  • 21. Genetic localisation of MRX27 to Xq24-26 defines another discrete gene for non-specific X-linked mental retardation.
    Gedeon AK; Glass IA; Connor JM; Mulley JC
    Am J Med Genet; 1996 Jul; 64(1):121-4. PubMed ID: 8826461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of a gene for X-linked agammaglobulinemia and evidence for genetic heterogeneity.
    Mensink EJ; Thompson A; Schot JD; van de Greef WM; Sandkuyl LA; Schuurman RK
    Hum Genet; 1986 Aug; 73(4):327-32. PubMed ID: 3502688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia.
    Peters TR; Brumbaugh DE; Lawton AR; Crowe JE
    Clin Infect Dis; 2000 Nov; 31(5):1287-8. PubMed ID: 11073766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.
    Aruffo A; Hollenbaugh D; Wu LH; Ochs HD
    Curr Opin Hematol; 1994 Jan; 1(1):12-8. PubMed ID: 9371254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Location on the human genetic linkage map of 26 genes involved in blood coagulation.
    Koeleman BP; Reitsma PH; Bakker E; Bertina RM
    Thromb Haemost; 1997 May; 77(5):873-8. PubMed ID: 9184395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic basis of the primary immunodeficiency syndromes.
    Adelman DC
    West J Med; 1995 Oct; 163(4):373-4. PubMed ID: 7483602
    [No Abstract]   [Full Text] [Related]  

  • 27. Further linkage evidence for localization of mutational sites for nonsyndromic types of X-linked mental retardation at the pericentromeric region.
    Robledo R; Melis P; Laficara F; Marchi J; Rinaldi A; Siniscalco M; Filippi G
    Am J Med Genet; 1996 Jul; 64(1):107-12. PubMed ID: 8826459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rheumatoid-like syndrome as a symptom of agammaglobulinemia].
    Amato GM; Barcellona R; Travia A; Amato G
    Minerva Pediatr; 1997 Sep; 49(9):425-7. PubMed ID: 9471547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of two X-linked mental retardation (XLMR) genes to Xp: MRX37 gene at Xp22.31-p22.32 and a putative MRX gene on Xp22.11-p22.2.
    Bar-David S; Lerer I; Sarfaty CK; Kohan ZG; Meiner V; Zlotogora J; Abeliovich D
    Am J Med Genet; 1996 Jul; 64(1):83-8. PubMed ID: 8826456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linkage analysis in three families with nonspecific X-linked mental retardation.
    Claes S; Gu XX; Legius E; Lorenzetti E; Marynen P; Fryns JP; Cassiman JJ; Raeymaekers P
    Am J Med Genet; 1996 Jul; 64(1):137-46. PubMed ID: 8826464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic mapping of X-linked ocular albinism: linkage analysis in a large Newfoundland kindred.
    Charles SJ; Green JS; Moore AT; Barton DE; Yates JR
    Genomics; 1993 Apr; 16(1):259-61. PubMed ID: 8486368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic linkage analysis identifies new proximal and distal flanking markers for the X-linked agammaglobulinemia gene locus, refining its localization in Xq22.
    Lovering R; Middleton-Price HR; O'Reilly MA; Genet SA; Parkar M; Sweatman AK; Bradley LD; Alterman LA; Malcolm S; Morgan G
    Hum Mol Genet; 1993 Feb; 2(2):139-41. PubMed ID: 8499902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolated GH deficiency with X-linked hypogammaglobulinemia].
    Nishimura S; Ueda K; Nishi Y
    Ryoikibetsu Shokogun Shirizu; 1993; (1):138-41. PubMed ID: 7757538
    [No Abstract]   [Full Text] [Related]  

  • 34. Refinement of the background genetic map of Xq26-q27 and gene localisation for Börjeson-Forssman-Lehmann Syndrome.
    Gedeon AK; Kozman HM; Robinson H; Pilia G; Schlessinger D; Turner G; Mulley JC
    Am J Med Genet; 1996 Jul; 64(1):63-8. PubMed ID: 8826450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent purulent triaditis in a patient with congenital x-linked agammaglobulinemia.
    Wray BB; Middleton HM; Mills LR; Plaxico DT; Otken LB
    Am J Gastroenterol; 1981 Feb; 75(2):140-3. PubMed ID: 7195149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of intraventricular gamma globulin to eradicate echovirus encephalitis in a patient with X-linked agammaglobulinemia.
    Johnson PR; Edwards KM; Wright PF
    N Engl J Med; 1985 Dec; 313(24):1546-7. PubMed ID: 2415820
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular analysis of X-linked immunodeficiency with hyper-IgM and X-linked lymphoproliferative syndrome.
    Notarangelo LD; Mantuano E; Bione S; Gimbo E; Giliani S; Caraffini A; Purtilo D; Farr C; Ugazio AG; Toniolo D
    Immunodeficiency; 1993; 4(1-4):225-9. PubMed ID: 8167706
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of linkage analysis using RFLP's.
    Chakravarti A
    Prog Clin Biol Res; 1984; 147():293-5. PubMed ID: 6588388
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of a genetic map of biallelic markers in linkage studies.
    Kruglyak L
    Nat Genet; 1997 Sep; 17(1):21-4. PubMed ID: 9288093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Degenerative encephalopathy of probable viral etiology in the course of congenital agammaglobulinemia].
    Neipp Lindenau C; Vargas Torcal F; Guinot Martínez E; de la Hoz Rosa J; Amelín Cahauve C
    An Esp Pediatr; 1990 Nov; 33(5):469-71. PubMed ID: 2096763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.